Aclaris Therapeutics, Inc.
NASDAQ: ACRS
Investor Relations

There are 0 Investigations and 1 Case being monitored for this company.

Case Name Date Filed Updated Status Securities
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) Investor Securities Class Action Lawsuit 07/30/2019 07/30/2019 11/24/ 2020 Lawsuit Filed NASDAQ: ACRS